Inventor
JIRGENSONS AIGARS
LV13 patents
⚠️ This page may combine multiple inventors who share the name “JIRGENSONS AIGARS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERZ PHARMA GMBH & CO KGAA
6 patentsUS6828462B2Dec 7, 2004
Unsaturated 1-amino-alkylcyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists
MERZ PHARMA GMBH & CO KGAA14 citations82
US6602862B1Aug 5, 2003
1-Amino-alkylcyclohexanes as trypanocidal agents
MERZ PHARMA GMBH & CO KGAA3 citations61
US7022729B2Apr 4, 2006
Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists
MERZ PHARMA GMBH & CO KGAA1 citations49
US7598384B2Oct 6, 2009
Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
MERZ PHARMA GMBH & CO KGAA1 citations48
US7238703B2Jul 3, 2007
Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists
MERZ PHARMA GMBH & CO KGAA0 citations47
US7550482B2Jun 23, 2009
Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors
MERZ PHARMA GMBH & CO KGAA0 citations37
OXFORD DRUG DESIGN LTD
3 patentsUS11072581B2Jul 27, 2021
N-acyl-arylsulfonamide derivatives as aminoacyl-tRNA synthetase inhibitors
OXFORD DRUG DESIGN LTD0 citations48
US11802110B2Oct 31, 2023
2-amino-N-(arylsulfinyl)-acetamide compounds as inhibitors of bacterial aminoacyl-tRNA synthetase
OXFORD DRUG DESIGN LTD0 citations39
US12247004B2Mar 11, 2025
2-amino-N-(amino-oxo-aryl-lambda6-sulfanylidene)acetamide compounds and their therapeutic use
OXFORD DRUG DESIGN LTD0 citations32